
Falcigo Artesunate Injection is a potent antimalarial medication designed for the treatment of severe and complicated malaria caused by Plasmodium falciparum. It contains Artesunate, a fast-acting derivative of artemisinin, known for its efficacy in rapidly reducing parasite load in the bloodstream.
Key Features:
Active Ingredient: Artesunate
Formulation: Injectable solution
Indication: Severe malaria, complicated malaria infections
Dosage Form: 60 mg / 120 mg per vial (depending on pack)
Mechanism of Action: Rapidly kills malaria parasites by targeting their red blood cell stage
Advantages: Fast onset of action, high efficacy, suitable for intravenous administration in severe cases
Usage & Administration:
Administered under medical supervision via intravenous or intramuscular injection. The dosage and duration depend on the patients age, weight, and severity of infection.
Storage:
Store in a cool, dry place away from direct sunlight. Keep out of reach of children.
Packaging:
Available in single-dose vials suitable for hospital and clinical use.

Price:
Price 6600.0 INR / Piece
Minimum Order Quantity : 1 Piece
Shelf Life : 24 months from the date of manufacture
Feature : Other, Enhances immune response, adjuvant therapy, biotechnologically manufactured
Ingredients : Other , Thymosin Alpha 1, Water for Injection, Preservatives
Temperature Needed For Fermentation : 30C 37C
Price 23500.0 INR / Piece
Minimum Order Quantity : 1 Piece
Shelf Life : 24 Hours
Feature : Other, Highly selective HER2 inhibitor
Ingredients : Other , Tucatinib and excipients
Temperature Needed For Fermentation : 28 Celsius (oC)
Price 15800.0 INR / Piece
Minimum Order Quantity : 1 Piece
Shelf Life : 24 Hours
Feature : Other, Tyrosine kinase inhibitor; oral targeted therapy
Ingredients : Other , Each filmcoated tablet contains Pazopanib (as hydrochloride) 400 mg and excipients
Temperature Needed For Fermentation : 28 Celsius (oC)
Price 9000.0 INR
Minimum Order Quantity : 1
Shelf Life : 24 months from the date of manufacture
Feature : Other, Human Monoclonal Antibody, Targeted Therapy for Bone Disorders
Ingredients : Other , Active: Denosumab; Excipients: Sorbitol, Acetate, Polysorbate 20, Water for Injection